BIT
SBBP

BlackRock Institutional Trust’s Strongbridge Biopharma plc. SBBP Stock Holding History

BlackRock Institutional Trust’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,147
Closed -$47K – 3971
2015
Q4 		$47K Buy
+6,147
New +$44.2K ﹤0.01% 3817

Other funds holding SBBP

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Institutional Trust's SBBP Position: Q1 2016 in Review

BlackRock Institutional Trust sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2016, closing a stake of 6,147 shares — an estimated $47K sold.

BlackRock Institutional Trust first reported a position in SBBP in Q4 2015 and held it in 1 quarter. The position peaked at $47K in Q4 2015. 15 funds tracked by Wall St. Rank hold SBBP as of Q1 2016.

  • BlackRock Institutional Trust reported no remaining Strongbridge Biopharma plc. position as of Q1 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 6,147 Strongbridge Biopharma plc. shares in Q1 2016, an estimated $47K.
  • BlackRock Institutional Trust first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 1 quarter.
  • BlackRock Institutional Trust's Strongbridge Biopharma plc. position peaked at $47K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2016.

Based on BlackRock Institutional Trust's 13F filing for Q1 2016, filed 10 May 2016.